Tara L Greenhow1, Yun-Yi Hung, Arnd M Herz, Elizabeth Losada, Robert H Pantell. 1. From the *Division of Infectious Diseases, Department of Pediatrics, Kaiser Permanente Northern California, San Francisco; †Division of Research, Kaiser Permanente Northern California, Oakland; ‡Division of Infectious Diseases, Department of Pediatrics, Kaiser Permanente Northern California, Hayward; §Department of Pediatrics, Kaiser Permanente Northern California, Oakland; and ¶Department of Pediatrics, Division of General Pediatrics, University of California, San Francisco, CA.
Abstract
BACKGROUND: Management of febrile young infants suspected of having serious bacterial infections has been a challenge for decades. The impact of changes in prenatal screening for Group B Streptococcus and of infant immunizations has received little attention in population-based studies. METHODS: This study analyzed all cultures of blood, urine and cerebrospinal fluid obtained from full-term infants 1 week to 3 months of age, who presented for care at Kaiser Permanente Northern California during a 7-year period utilizing electronic medical records. RESULTS: A total of 224,553 full-term infants were born during the study period. Of 5396 blood cultures, 129 bacteremic infants were identified (2%). Of 4599 urine cultures, 823 episodes of urinary tract infection (UTI) were documented in 778 infants (17%). Of 1796 CSF cultures, 16 infants had bacterial meningitis (0.9%). The incidence rate of serious bacterial infections (bacteremia, UTI and meningitis) and febrile serious bacterial infections was 3.75 and 3.1/1000 full-term births, respectively. Escherichia coli was the leading cause of bacteremia (78), UTI (719) and bacterial meningitis (7). There were 23 infants with Group B Streptococcus bacteremia including 6 cases of meningitis and no cases of Listeria infection. Nine percentage of infants had multiple sites of infection; 10% of UTIs were associated with bacteremia and 52% of bacteremia was associated with UTI. CONCLUSIONS: Compared with earlier studies, UTIs now are found significantly more often than bacteremia and meningitis with 92% of occult infections associated with UTIs. These data emphasize the importance of an urinalysis in febrile infants.
BACKGROUND: Management of febrile young infants suspected of having serious bacterial infections has been a challenge for decades. The impact of changes in prenatal screening for Group B Streptococcus and of infant immunizations has received little attention in population-based studies. METHODS: This study analyzed all cultures of blood, urine and cerebrospinal fluid obtained from full-term infants 1 week to 3 months of age, who presented for care at Kaiser Permanente Northern California during a 7-year period utilizing electronic medical records. RESULTS: A total of 224,553 full-term infants were born during the study period. Of 5396 blood cultures, 129 bacteremic infants were identified (2%). Of 4599 urine cultures, 823 episodes of urinary tract infection (UTI) were documented in 778 infants (17%). Of 1796 CSF cultures, 16 infants had bacterial meningitis (0.9%). The incidence rate of serious bacterial infections (bacteremia, UTI and meningitis) and febrile serious bacterial infections was 3.75 and 3.1/1000 full-term births, respectively. Escherichia coli was the leading cause of bacteremia (78), UTI (719) and bacterial meningitis (7). There were 23 infants with Group B Streptococcus bacteremia including 6 cases of meningitis and no cases of Listeria infection. Nine percentage of infants had multiple sites of infection; 10% of UTIs were associated with bacteremia and 52% of bacteremia was associated with UTI. CONCLUSIONS: Compared with earlier studies, UTIs now are found significantly more often than bacteremia and meningitis with 92% of occult infections associated with UTIs. These data emphasize the importance of an urinalysis in febrile infants.
Authors: Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham Journal: Clin Microbiol Rev Date: 2014-10 Impact factor: 26.132
Authors: Elana A Feldman; Russell J McCulloh; Angela L Myers; Paul L Aronson; Mark I Neuman; Miranda C Bradford; Elizabeth R Alpern; Frances Balamuth; Mercedes M Blackstone; Whitney L Browning; Katie Hayes; Rosalynne Korman; Rianna C Leazer; Lise E Nigrovic; Richard Marble; Emily Roben; Derek J Williams; Joel S Tieder Journal: Hosp Pediatr Date: 2017-07-20
Authors: Andrea T Cruz; Prashant Mahajan; Bema K Bonsu; Jonathan E Bennett; Deborah A Levine; Elizabeth R Alpern; Lise E Nigrovic; Shireen M Atabaki; Daniel M Cohen; John M VanBuren; Octavio Ramilo; Nathan Kuppermann Journal: JAMA Pediatr Date: 2017-11-06 Impact factor: 16.193
Authors: Leah Tzimenatos; Prashant Mahajan; Peter S Dayan; Melissa Vitale; James G Linakis; Stephen Blumberg; Dominic Borgialli; Richard M Ruddy; John Van Buren; Octavio Ramilo; Nathan Kuppermann Journal: Pediatrics Date: 2018-01-16 Impact factor: 7.124